Company Analysis

BriaCell Therapeutics Corp. (BCTX)

Nasdaq: BCTX · Pharmaceutical Preparations · West Vancouver, BC · filing with the SEC since 2014
Grade4.4
◀ Past 3.5● Present 3.8▶ Future 5.4
7 est.

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in July.
Income statement, by fiscal year, newest first
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022FY 2022FY 2021FY 2021
Period endingJul 31, 2026Jul 31, 2025Jul 31, 2024Jul 31, 2023Jul 31, 2022Jun 30, 2022Jul 31, 2021Jun 30, 2021
Report filedOct 28, 2026Oct 16, 2025Oct 29, 2024Oct 25, 2023Oct 28, 2022·Oct 29, 2021·
Research and development29,236,50821,270,67827,177,80715,336,6388,021,489·2,020,899·
General and administrative6,817,7295,934,1256,152,2697,935,6267,267,452·4,955,136·
Total operating expenses36,054,23727,204,80333,330,07623,272,264····
Operating income-36,054,237-27,204,803-33,330,076-23,272,264-15,288,941·-6,976,035·
Interest expense29,63136,979··979·78,554·
Interest and investment income633,766119,958288,018891,213136,731·3,149·
Share of profit of equity-method investments-263,477-224,212-106,510·····
Total non-operating income (expense)601,461114,511262,566850,340r-11,549,962·-6,840,165·
Income before income taxes35,325,29226,556,1404,931,54820,302,394r-26,838,903·-13,816,200·
Income tax expense·····0·0
Net income including non-controlling interests-35,325,292-26,556,140-4,931,548-20,302,394····
Net income to non-controlling interests-421,030-244,273-140,082·····
Net income-34,904,262-26,311,867-4,791,466-20,302,394-26,838,903·-13,816,200·
Net income to common shareholders-34,904,262-26,311,867-4,791,466r-20,302,394-26,838,903·-13,816,200·
Earnings per share, basic-6.97-62.19-43.68r-195.00b-259.50b·-459.00b·
Earnings per share, diluted-6.97-62.19-43.68r-195.00b-259.50b···
Weighted average shares, basic5,010,907423,114109,699r104,131b103,294b·30,131b·
Weighted average shares, diluted5,010,907423,114109,699r104,131b103,294b···
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-150 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
Share of profit of equity-method investments its share of companies it partly ownsus-gaap:IncomeLossFromEquityMethodInvestments
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income to non-controlling interests the share that belongs to minority holdersus-gaap:NetIncomeLossAttributableToNoncontrollingInterest
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
SI Assistanton BCTX · research, not advice